Carl Garbus, OD, FAAO, shares insights from his discussion that he copresented during the 2023 AOA Optometry's Meeting in Washington, DC.
An emerging treatment approach for a commonly underdiagnosed ocular surface disease.
Results of the BRIO-I study, the first of 2 phase 3 clinical trials of Brimochol PF, a topical, fixed-dose combination for the treatment of presbyopia, have recently been released.
Michelle Buckland, OD, MS, FAAO, shares highlights from her 2022 American Academy of Optometry presentation, "Pediatric eye exams: the ABCs and 123s."
Community-based eye care is one of Orbis’s top priorities in the country.
Michelle Hoff, OD, FAAO, ABOM, FNAO, and Isabel Kazemi, OD, FAAO, share key takeaways from their VEW 2022 presentation, "The ABCs on pediatric vision."
Understanding the precise formulation of pharmacologic agents for refractive correction for presbyopia.
Research into multiple aspects of myopia control warranted.
In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.
An overview of the factors of lens development and their application in the real world for patients with presbyopia.
William Reindel, OD, discusses how pupil size affects fit and comfort in multifocal contact lens wearers.
The important role eye care providers play in lessening the burden of myopia treatment for pediatric specialists.
Luis Rojas, OD, shares his tips and tricks for getting the best fit for multifocal contact lenses, as well as how to leverage custom fittings as a service as a marketing tool.
Jason Compton, OD, shares highlights from his VEW 2022 presentation, "Marketing for specialty lens practice."
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
The first approved GA treatment leaves room for additional therapies.
Bindu Manne, lead of Market Development for Ocuphire, shares a company update.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Jason S. Ng, OD, PhD, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Cannabis and vision: acute effects."
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients
New treatments for geographic atrophy coming down the pike has the potential to change eye care providers' approach to identifying and managing the disease.
Presbyopia awareness: Causes, risk factors, symptoms, correction options and market trends.
How Jimmie Johnson relieves his ocular allergies
Spectacle independence, nighttime glare symptoms often are key factors.
At the Tear Film and Ocular Surface meeting in Venice, Dr. Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.
Patients with HTG had significantly fewer mtDNA copies per nuclear DNA.
An increase in screen time has led to a rise in binocular vision disorders.
An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.